The Detroit Medical Center is a for-profit alliance of hospitals that encompasses over 2,000 licensed beds, 3,000 affiliated physicians and over 12,000 employees. Located in Midtown Detroit, the DMC is affiliated with medical schools from Wayne State University and Michigan State University.

During the past decade, Wayne State University - Detroit Receiving Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wayne State University - Detroit Receiving Hospital" #1 sponsor was "BrainScope Company, Inc." with 4 trials, followed by "Banyan Biomarkers, Inc" with 2 trials sponsored, "Atox Bio Ltd" with 1 trials sponsored, "Biosite" with 1 trials sponsored and "Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wayne State University - Detroit Receiving Hospital" #1 collaborator was "BMEYE BV the Netherlands" with 1 trials as a collaborator, "Beijing Tiantan Hospital" with 1 trials as a collaborator, "BioMérieux" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "China Medical University Hospital" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Wayne State University - Detroit Receiving Hospital" are "Brain Injuries" (3 trials), "Traumatic Brain Injury" (2 trials), "Acute CHF" (1 trials), "Acute Coronary Syndrome (ACS)" (1 trials) and "Acute Stroke Syndromes" (1 trials). Many other conditions were trialed in "Wayne State University - Detroit Receiving Hospital" in a lesser frequency.

Most popular intervention types in "Wayne State University - Detroit Receiving Hospital" are "Other" (7 trials), "Device" (4 trials), "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "BrainScope Ahead 200" (2 trials), "Placebo" (2 trials), "22-item CSI" (1 trials), "AB103 0.5 mg/kg" (1 trials) and "Blood draw within 12 hours of head injury" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wayne State University - Detroit Receiving Hospital" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Wayne State University - Detroit Receiving Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Wayne State University - Detroit Receiving Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wayne State University - Detroit Receiving Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".